Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States

Authors:

Abstract
No abstract available
Funding Information
  • National Institute of Allergy and Infectious Diseases
  • Merck Sharp and Dohme United Kingdom
  • Health Resources and Services Administration (HHSH250201700006C, N00014-20-1-2705, N00014-20-1-2832)
  • Angiocrine Bioscience
  • Intel Corporation
  • Kyowa Kirin Pharmaceutical Development
  • Amgen
  • CSL Behring
  • National Cancer Institute
  • Medical College of Wisconsin
  • Celgene
  • National Institutes of Health
  • AbbVie
  • Office of Naval Research
  • U.S. Public Health Service (U24CA076518)
  • National Heart, Lung, and Blood Institute
  • Daiichi-Sankyo
  • Astellas Pharma US
  • Gilead Sciences

This publication has 33 references indexed in Scilit: